Riskpilot← Back to searchSign inGet full accessOXYO AS
ASActiveOrg 924588071Ørtfjellveien 64, 8630 StorforsheiaWholesale of pharmaceutical and medical goods · NACE 4646Est. 20200 employees
Revenue 2024
NOK 487K
+13% vs 2023
EBITDA margin
14.9%
-69% vs 2023
Equity ratio
47.0%
Financial strength
Net profit 2024
NOK -48K
-136% vs 2023
| Revenue | NOK 487K | +13% |
| EBITDA | NOK 73K | -69% |
| Net profit | NOK -48K | -136% |
| Total assets | NOK 2,1M | +95% |
| Equity | NOK 1M | +1737% |
| Employees | 0 | — |
Legal name
OXYO AS
Org number
924588071
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12. februar 2020
Share capital
NOK 1 030 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Salg og utvikling av helserelaterte produkter og tjenester.
Address
Ørtfjellveien 64, 8630 Storforsheia
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 36 | 0 | 430 | 487 |
| Staff expenses | −0 | −0 | −0 | −3 | −45 |
| EBITDA | 0 | 7 | −9 | 233 | 73 |
| Depreciation & amort. | −0 | −12 | −86 | −94 | −113 |
| EBIT | 0 | −5 | −95 | 139 | −40 |
| Net financials | 0 | −4 | −3 | 0 | −21 |
| Profit before tax | 0 | −9 | −98 | 139 | −62 |
| Tax | −0 | −2 | 2 | 7 | −14 |
| Net profit | 0 | −7 | −100 | 132 | −48 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 30 | 552 | 605 | 1 098 | 2 141 |
| Equity | 30 | 23 | −78 | 55 | 1 007 |
| Long-term debt | 0 | 0 | 0 | 861 | 51 |
| Short-term debt | 0 | 529 | 682 | 183 | 1 084 |
| Total debt | 0 | 529 | 682 | 1 044 | 1 134 |
EBITDA margin
14.9%
This company
15.8%
Market median
-6% vs market
20202024
Equity ratio
47.0%
This company
38.2%
Market median
+23% vs market
20202024
Return on equity
-4.8%
This company
18.4%
Market median
-126% vs market
20202024
Net profit margin
-9.9%
This company
8.1%
Market median
-222% vs market
20202024
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
20202024
Debt / equity
1.13×
This company
0.62×
Market median
-82% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JI Chief Executive Officer | Chief Executive Officer | 2023 |
LM Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Chairman | 2024 | |
| Chairman | 2023 | |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OXYO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørn Inge Eivik | Chief Executive Officer | 0 companies |
| Lise Marie Johansen | Chief Executive Officer | 0 companies |
| Ole Petter Braathen | Board of Directors | 0 companies |
| Øyvind Brattland | Chairman | 0 companies |
| Kjell Dagfinn Braathen | Chairman | 0 companies |